LCN2 and Sepsis: Urine NGAL, uATF3, and both values in combination enhanced predictive risk in 67%, 69% and 49%, respectively, in sepsis-AKI patients, and 35%, 44% and 52%, respectively, in sepsis-non-AKI patients.